Skybiotech Healthcare Limited (BOM:512036)

Skybiotech Healthcare Statistics

Total Valuation

BOM:512036 has a market cap or net worth of INR 302.09 million. The enterprise value is 404.78 million.

Market Cap	302.09M
Enterprise Value	404.78M

Important Dates

The last earnings date was Saturday, May 30, 2026.

Earnings Date	May 30, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:512036 has 1.92 million shares outstanding. The number of shares has decreased by -12.96% in one year.

Current Share Class	1.92M
Shares Outstanding	1.92M
Shares Change (YoY)	-12.96%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	92.01%
Owned by Institutions (%)	n/a
Float	153,004

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.08
PB Ratio	3.26
P/TBV Ratio	6.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-36.24
EV / Sales	5.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-26.67

Financial Position

The company has a current ratio of 0.68, with a Debt / Equity ratio of 0.91.

Current Ratio	0.68
Quick Ratio	0.26
Debt / Equity	0.91
Debt / EBITDA	n/a
Debt / FCF	-5.54
Interest Coverage	-77.99

Financial Efficiency

Return on equity (ROE) is -11.29% and return on invested capital (ROIC) is -9.01%.

Return on Equity (ROE)	-11.29%
Return on Assets (ROA)	-5.20%
Return on Invested Capital (ROIC)	-9.01%
Return on Capital Employed (ROCE)	-9.40%
Weighted Average Cost of Capital (WACC)	-3.29%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.37
Inventory Turnover	3.27

Taxes

Income Tax	-5.50M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.65% in the last 52 weeks. The beta is -1.55, so BOM:512036's price volatility has been lower than the market average.

Beta (5Y)	-1.55
52-Week Price Change	-2.65%
50-Day Moving Average	144.24
200-Day Moving Average	176.87
Relative Strength Index (RSI)	56.17
Average Volume (20 Days)	54

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:512036 had revenue of INR 74.04 million and -11.17 million in losses. Loss per share was -6.70.

Revenue	74.04M
Gross Profit	34.94M
Operating Income	-16.46M
Pretax Income	-16.67M
Net Income	-11.17M
EBITDA	-11.67M
EBIT	-16.46M
Loss Per Share	-6.70

Balance Sheet

The company has -5.94 million in cash and 84.15 million in debt, with a net cash position of -90.10 million or -47.05 per share.

Cash & Cash Equivalents	-5.94M
Total Debt	84.15M
Net Cash	-90.10M
Net Cash Per Share	-47.05
Equity (Book Value)	92.53M
Book Value Per Share	n/a
Working Capital	-6.14M

Cash Flow

In the last 12 months, operating cash flow was -15.16 million and capital expenditures -22,000, giving a free cash flow of -15.18 million.

Operating Cash Flow	-15.16M
Capital Expenditures	-22,000
Depreciation & Amortization	4.79M
Net Borrowing	11.91M
Free Cash Flow	-15.18M
FCF Per Share	-7.93

Margins

Gross margin is 47.19%, with operating and profit margins of -22.23% and -15.08%.

Gross Margin	47.19%
Operating Margin	-22.23%
Pretax Margin	-22.51%
Profit Margin	-15.08%
EBITDA Margin	-15.76%
EBIT Margin	-22.23%
FCF Margin	n/a

Dividends & Yields

BOM:512036 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	12.96%
Shareholder Yield	12.96%
Earnings Yield	-3.70%
FCF Yield	-5.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a